Skip to main content
Top
Published in: Endocrine 2/2014

01-11-2014 | Original Article

Evaluation of left ventricle functions by tissue Doppler, strain, and strain rate echocardiography in patients with primary hyperparathyroidism

Authors: Didem Ozdemir, Gulhan Yuksel Kalkan, Nihal Akar Bayram, Eda Demir Onal, Reyhan Ersoy, Engin Bozkurt, Bekir Cakir

Published in: Endocrine | Issue 2/2014

Login to get access

Abstract

Cardiovascular morbidity and mortality are increased in patients with primary hyperparathyroidism (PHPT). We aimed to evaluate left ventricle systolic and diastolic functions with tissue Doppler imaging (TDI) and strain and strain rate echocardiography in patients with PHPT. Thirty-one patients with PHPT and 29 healthy controls were evaluated with conventional and pulse Doppler echocardiography, TDI and strain and strain rate echocardiography. Myocardial performance index (MPI) was calculated. Strain and peak systolic strain rate in mid and basal segments of lateral, anterior, inferior, and septal walls of left ventricle were determined. TDI showed similar late diastolic myocardial peak velocity in two groups. Peak systolic mitral annular velocity, early diastolic myocardial peak velocity, and ratio of early to late diastolic myocardial peak velocity were lower in PHPT patients (p = 0.01, p < 0.001 and p < 0.001, respectively). MPI calculated by TDI was 0.53 ± 0.15 in PHPT group and 0.44 ± 0.09 in control group (p = 0.013). Strain values were lower in mid and basal segments of septum, lateral and anterior walls, and basal segment of inferior wall in PHPT patients. Mean systolic strain was −20.88 ± 2.30 and −24.25 ± 2.13 in PHPT patients and control group, respectively (p < 0.001). Mean strain rate was lower in PHPT patients compared to control group (−1.38 ± 0.19 vs −1.57 ± 0.25) (p = 0.002). Patients with PHPT, but no cardiac symptoms or documented cardiovascular disease, have subclinical systolic and diastolic myocardial dysfunction. Evaluation of these patients with TDI and S and Sr echocardiography in addition to conventional echocardiography might be valuable to detect subclinical cardiac involvement.
Literature
1.
go back to reference S.J. Marx, Hyperparathyroid and hypoparathyroid disorders. N. Engl. J. Med. 343, 1863–1875 (2000)PubMedCrossRef S.J. Marx, Hyperparathyroid and hypoparathyroid disorders. N. Engl. J. Med. 343, 1863–1875 (2000)PubMedCrossRef
2.
go back to reference G. Hedbäck, A. Odén, Increased risk of death from primary hyperparathyroidism–an update. Eur. J. Clin. Invest. 28(4), 271–276 (1998)PubMedCrossRef G. Hedbäck, A. Odén, Increased risk of death from primary hyperparathyroidism–an update. Eur. J. Clin. Invest. 28(4), 271–276 (1998)PubMedCrossRef
3.
go back to reference I.L. Nilsson, L. Yin, E. Lundgren, J. Rastad, A. Ekbom, Clinical presentation of primary hyperparathyroidism in Europe–nationwide cohort analysis on mortality from nonmalignant causes. J. Bone Miner. Res. 17(Suppl 2), N68–N74 (2002)PubMed I.L. Nilsson, L. Yin, E. Lundgren, J. Rastad, A. Ekbom, Clinical presentation of primary hyperparathyroidism in Europe–nationwide cohort analysis on mortality from nonmalignant causes. J. Bone Miner. Res. 17(Suppl 2), N68–N74 (2002)PubMed
4.
go back to reference K.D. Schlüter, M. Weber, H.M. Piper, Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem. J. 310(Pt 2), 439–444 (1995)PubMedPubMedCentral K.D. Schlüter, M. Weber, H.M. Piper, Parathyroid hormone induces protein kinase C but not adenylate cyclase in adult cardiomyocytes and regulates cyclic AMP levels via protein kinase C-dependent phosphodiesterase activity. Biochem. J. 310(Pt 2), 439–444 (1995)PubMedPubMedCentral
5.
go back to reference E. Hagström, P. Hellman, T.E. Larsson, E. Ingelsson, L. Berglund, J. Sundström, H. Melhus, C. Held, L. Lind, K. Michaëlsson, J. Arnlöv, Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119(21), 2765–2771 (2009)PubMedCrossRef E. Hagström, P. Hellman, T.E. Larsson, E. Ingelsson, L. Berglund, J. Sundström, H. Melhus, C. Held, L. Lind, K. Michaëlsson, J. Arnlöv, Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 119(21), 2765–2771 (2009)PubMedCrossRef
6.
go back to reference P.J. Buizert, N.M. van Schoor, S. Simsek, P. Lips, A.C. Heijboer, M. den Heijer, D.J. Deeg, E.M. Eekhoff, PTH: a new target in arteriosclerosis? J. Clin. Endocrinol. Metab. 98(10), E1583–E1590 (2013)PubMedCrossRef P.J. Buizert, N.M. van Schoor, S. Simsek, P. Lips, A.C. Heijboer, M. den Heijer, D.J. Deeg, E.M. Eekhoff, PTH: a new target in arteriosclerosis? J. Clin. Endocrinol. Metab. 98(10), E1583–E1590 (2013)PubMedCrossRef
7.
go back to reference K. Dalberg, L.A. Brodin, A. Juhlin-Dannfelt, L.O. Farnebo, Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur. J. Surg. 162(3), 171–176 (1996)PubMed K. Dalberg, L.A. Brodin, A. Juhlin-Dannfelt, L.O. Farnebo, Cardiac function in primary hyperparathyroidism before and after operation. An echocardiographic study. Eur. J. Surg. 162(3), 171–176 (1996)PubMed
8.
go back to reference T. Stefenelli, C. Abela, H. Frank, J. Koller-Strametz, S. Globits, J. Bergler-Klein, B. Niederle, Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J. Clin. Endocrinol. Metab. 82(1), 106–112 (1997)PubMedCrossRef T. Stefenelli, C. Abela, H. Frank, J. Koller-Strametz, S. Globits, J. Bergler-Klein, B. Niederle, Cardiac abnormalities in patients with primary hyperparathyroidism: implications for follow-up. J. Clin. Endocrinol. Metab. 82(1), 106–112 (1997)PubMedCrossRef
9.
go back to reference T. Stefenelli, H. Mayr, J. Bergler-Klein, S. Globits, W. Woloszczuk, B. Niederle, Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am. J. Med. 95(2), 197–202 (1993)PubMedCrossRef T. Stefenelli, H. Mayr, J. Bergler-Klein, S. Globits, W. Woloszczuk, B. Niederle, Primary hyperparathyroidism: incidence of cardiac abnormalities and partial reversibility after successful parathyroidectomy. Am. J. Med. 95(2), 197–202 (1993)PubMedCrossRef
10.
go back to reference A. Piovesan, N. Molineri, F. Casasso, I. Emmolo, G. Ugliengo, F. Cesario, G. Borretta, Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin. Endocrinol. (Oxf) 50(3), 321–328 (1999)CrossRef A. Piovesan, N. Molineri, F. Casasso, I. Emmolo, G. Ugliengo, F. Cesario, G. Borretta, Left ventricular hypertrophy in primary hyperparathyroidism. Effects of successful parathyroidectomy. Clin. Endocrinol. (Oxf) 50(3), 321–328 (1999)CrossRef
11.
go back to reference G. Barletta, M.L. De Feo, R. Del Bene, C. Lazeri, S. Vecchiarino, G. La Villa, M.L. Brandi, F. Franchi, Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 85(5), 1815–1821 (2000)PubMed G. Barletta, M.L. De Feo, R. Del Bene, C. Lazeri, S. Vecchiarino, G. La Villa, M.L. Brandi, F. Franchi, Cardiovascular effects of parathyroid hormone: a study in healthy subjects and normotensive patients with mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 85(5), 1815–1821 (2000)PubMed
12.
go back to reference N. Ohara, K. Hiramatsu, S. Shigematsu, Y. Hayashi, F. Ishihara, T. Aizawa, A. Niwa, T. Yamada, K. Hashizume, Effect of parathyroid hormone on left ventricular diastolic function in patients with primary hyperparathyroidism. Miner. Electrolyte Metab. 21(1–3), 63–66 (1995)PubMed N. Ohara, K. Hiramatsu, S. Shigematsu, Y. Hayashi, F. Ishihara, T. Aizawa, A. Niwa, T. Yamada, K. Hashizume, Effect of parathyroid hormone on left ventricular diastolic function in patients with primary hyperparathyroidism. Miner. Electrolyte Metab. 21(1–3), 63–66 (1995)PubMed
13.
go back to reference I.L. Nilsson, J. Aberg, J. Rastad, L. Lind, Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery 128(6), 895–902 (2000)PubMedCrossRef I.L. Nilsson, J. Aberg, J. Rastad, L. Lind, Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy. Surgery 128(6), 895–902 (2000)PubMedCrossRef
14.
go back to reference E. Osto, F. Fallo, M.R. Pelizzo, A. Maddalozzo, N. Sorgato, F. Corbetti, R. Montisci, G. Famoso, R. Bellu, T.F. Lüscher, S. Iliceto, F. Tona, Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy. Circulation 126, 1031–1039 (2012)PubMedCrossRef E. Osto, F. Fallo, M.R. Pelizzo, A. Maddalozzo, N. Sorgato, F. Corbetti, R. Montisci, G. Famoso, R. Bellu, T.F. Lüscher, S. Iliceto, F. Tona, Coronary microvascular dysfunction induced by primary hyperparathyroidism is restored after parathyroidectomy. Circulation 126, 1031–1039 (2012)PubMedCrossRef
15.
go back to reference M.J. Garcia, J.D. Thomas, A.L. Klein, New Doppler echocardiographic applications for the study of diastolic function. J. Am. Coll. Cardiol. 32(4), 865–875 (1998)PubMedCrossRef M.J. Garcia, J.D. Thomas, A.L. Klein, New Doppler echocardiographic applications for the study of diastolic function. J. Am. Coll. Cardiol. 32(4), 865–875 (1998)PubMedCrossRef
16.
go back to reference F. Weidemann, F. Jamal, G.R. Sutherland, P. Claus, L. Hatle, I. De Scheerder, B. Bijnens, F.E. Rademakers, Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate. Physiol. Heart. Circ. Physiol 283(2), H792–H799 (2002) F. Weidemann, F. Jamal, G.R. Sutherland, P. Claus, L. Hatle, I. De Scheerder, B. Bijnens, F.E. Rademakers, Myocardial function defined by strain rate and strain during alterations in inotropic states and heart rate. Physiol. Heart. Circ. Physiol 283(2), H792–H799 (2002)
17.
go back to reference D. Pelerin, L. Cohen, F. Larrazet, F. Extramiana, S. Witchitz, C. Veyrat, New insights into septal anterior wall motion velocities at end-systole in normal and hypertrophied left ventricles. Eur. J. Echocardiography 4, 108–118 (2003)CrossRef D. Pelerin, L. Cohen, F. Larrazet, F. Extramiana, S. Witchitz, C. Veyrat, New insights into septal anterior wall motion velocities at end-systole in normal and hypertrophied left ventricles. Eur. J. Echocardiography 4, 108–118 (2003)CrossRef
18.
go back to reference M. Baykan, C. Erem, T. Erdogan, H.O. Ersöz, O. Gedikli, L. Korkmaz, Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clin. Endocrinol. (Oxf) 66(4), 483 (2007) M. Baykan, C. Erem, T. Erdogan, H.O. Ersöz, O. Gedikli, L. Korkmaz, Assessment of left ventricular diastolic function and the Tei index by tissue Doppler imaging in patients with primary hyperparathyroidism. Clin. Endocrinol. (Oxf) 66(4), 483 (2007)
19.
go back to reference P. Farahnak, M. Ring, K. Caidahl, L.O. Farnebo, M.J. Eriksson, I.L. Nilsson, Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy. Eur. J. Endocrinol. 163(3), 461–467 (2010)PubMedCrossRefPubMedCentral P. Farahnak, M. Ring, K. Caidahl, L.O. Farnebo, M.J. Eriksson, I.L. Nilsson, Cardiac function in mild primary hyperparathyroidism and the outcome after parathyroidectomy. Eur. J. Endocrinol. 163(3), 461–467 (2010)PubMedCrossRefPubMedCentral
20.
go back to reference M.D. Walker, J.B. Fleischer, M.R. Di Tullio, S. Homma, T. Rundek, E.M. Stein, Cardiac structure and diastolic function in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 95(5), 2172–2179 (2010)PubMedCrossRefPubMedCentral M.D. Walker, J.B. Fleischer, M.R. Di Tullio, S. Homma, T. Rundek, E.M. Stein, Cardiac structure and diastolic function in mild primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 95(5), 2172–2179 (2010)PubMedCrossRefPubMedCentral
21.
go back to reference J.P. Bilezikian, J.T. Potts Jr., Gel-H. Fuleihan, M. Kleerekoper, R. Neer, M. Peacock, J. Rastad, S.J. Silverberg, R. Udelsman, S.A. Wells Jr., Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J. Bone Miner. Res. 17(suppl 2), N2–N11 (2002) J.P. Bilezikian, J.T. Potts Jr., Gel-H. Fuleihan, M. Kleerekoper, R. Neer, M. Peacock, J. Rastad, S.J. Silverberg, R. Udelsman, S.A. Wells Jr., Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J. Bone Miner. Res. 17(suppl 2), N2–N11 (2002)
22.
go back to reference A.S. Pearlman, J.M. Gadrin, R.P. Martin, A.F. Parisi, R.L. Popp, M.A. Quinones, J.G. Stevenson, Guidelines for optimal physician training in echocardiography. Recommendations of the American Society of Echocardiography committee for physician training in echocardiography. Am. J. Cardiol. 60, 158–163 (1987)PubMedCrossRef A.S. Pearlman, J.M. Gadrin, R.P. Martin, A.F. Parisi, R.L. Popp, M.A. Quinones, J.G. Stevenson, Guidelines for optimal physician training in echocardiography. Recommendations of the American Society of Echocardiography committee for physician training in echocardiography. Am. J. Cardiol. 60, 158–163 (1987)PubMedCrossRef
23.
go back to reference D. Pelerin, R. Sharma, P. Elliott, C. Veyrat, Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 89 (Suppl iii), iii9–iii17 (2003) D. Pelerin, R. Sharma, P. Elliott, C. Veyrat, Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function. Heart 89 (Suppl iii), iii9–iii17 (2003)
24.
go back to reference H. Ronni-Sivula, Causes of death in patients previously operated on for primary hyperparathyroidism. Ann. Chir. Gynaecol. 74(1), 13–18 (1985)PubMed H. Ronni-Sivula, Causes of death in patients previously operated on for primary hyperparathyroidism. Ann. Chir. Gynaecol. 74(1), 13–18 (1985)PubMed
25.
go back to reference I.L. Nilsson, C. Wadsten, L. Brandt, J. Rastad, A. Ekbom, Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. Surgery. 136(5), 981–987 (2004)PubMedCrossRef I.L. Nilsson, C. Wadsten, L. Brandt, J. Rastad, A. Ekbom, Mortality in sporadic primary hyperparathyroidism: nationwide cohort study of multiple parathyroid gland disease. Surgery. 136(5), 981–987 (2004)PubMedCrossRef
26.
go back to reference B.G. Leifsson, B. Ahrén, Serum calcium and survival in a large health screening program. J. Clin. Endocrinol. Metab. 81(6), 2149–2153 (1996)PubMed B.G. Leifsson, B. Ahrén, Serum calcium and survival in a large health screening program. J. Clin. Endocrinol. Metab. 81(6), 2149–2153 (1996)PubMed
27.
go back to reference L. Lind, E. Skarfors, L. Berglund, H. Lithell, S. Ljunghall, Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J. Clin. Epidemiol. 50(8), 967–973 (1996)CrossRef L. Lind, E. Skarfors, L. Berglund, H. Lithell, S. Ljunghall, Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years. J. Clin. Epidemiol. 50(8), 967–973 (1996)CrossRef
28.
go back to reference N. Yu, P.T. Donnan, R.W. Flynn, M.J. Murphy, D. Smith, A. Rudman, G.P. Leese, Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin. Endocrinol. (Oxf) 73(1), 30–34 (2010) N. Yu, P.T. Donnan, R.W. Flynn, M.J. Murphy, D. Smith, A. Rudman, G.P. Leese, Increased mortality and morbidity in mild primary hyperparathyroid patients. The Parathyroid Epidemiology and Audit Research Study (PEARS). Clin. Endocrinol. (Oxf) 73(1), 30–34 (2010)
29.
go back to reference M. Procopio, M. Barale, S. Bertaina, S. Sigrist, R. Mazzetti, M. Loiacono, G. Mengozzi, E. Ghigo, M. Maccario, Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine. (2013). [Epub ahead of print] doi:10.1007/s12020-013-0091-z M. Procopio, M. Barale, S. Bertaina, S. Sigrist, R. Mazzetti, M. Loiacono, G. Mengozzi, E. Ghigo, M. Maccario, Cardiovascular risk and metabolic syndrome in primary hyperparathyroidism and their correlation to different clinical forms. Endocrine. (2013). [Epub ahead of print] doi:10.​1007/​s12020-013-0091-z
30.
go back to reference M.R. Rubin, S.J. Silverberg, Glucose intolerance and primary hyperparathyroidism: an unresolved relationship. Endocrine 42(2), 231–233 (2012)PubMedCrossRef M.R. Rubin, S.J. Silverberg, Glucose intolerance and primary hyperparathyroidism: an unresolved relationship. Endocrine 42(2), 231–233 (2012)PubMedCrossRef
31.
go back to reference D. Han, S. Trooskin, X. Wang, Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism. J. Endocrinol. Invest. 35(6), 548–552 (2012)PubMed D. Han, S. Trooskin, X. Wang, Prevalence of cardiovascular risk factors in male and female patients with primary hyperparathyroidism. J. Endocrinol. Invest. 35(6), 548–552 (2012)PubMed
32.
go back to reference F. Längle, C. Abela, J. Koller-Strametz, M. Mittelböck, J. Bergler-Klein, T. Stefenelli, Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data. World J. Surg. 18(4), 619–624 (1994)PubMedCrossRef F. Längle, C. Abela, J. Koller-Strametz, M. Mittelböck, J. Bergler-Klein, T. Stefenelli, Primary hyperparathyroidism and the heart: cardiac abnormalities correlated to clinical and biochemical data. World J. Surg. 18(4), 619–624 (1994)PubMedCrossRef
33.
go back to reference J.L. Anderson, R.C. Vanwoerkom, B.D. Horne, T.L. Bair, H.T. May, D.L. Lappé, J.B. Muhlestein, Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am. Heart J. 162(2), 331–339 (2011)PubMedCrossRef J.L. Anderson, R.C. Vanwoerkom, B.D. Horne, T.L. Bair, H.T. May, D.L. Lappé, J.B. Muhlestein, Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am. Heart J. 162(2), 331–339 (2011)PubMedCrossRef
34.
go back to reference X. Liu, R. Xie, S. Liu, Rat parathyroid hormone 1-34 signals through the MEK/ERK pathway to induce cardiac hypertrophy. J. Int. Med. Res. 36(5), 942–950 (2008)PubMedCrossRef X. Liu, R. Xie, S. Liu, Rat parathyroid hormone 1-34 signals through the MEK/ERK pathway to induce cardiac hypertrophy. J. Int. Med. Res. 36(5), 942–950 (2008)PubMedCrossRef
35.
go back to reference L. Brunaud, A. Germain, R. Zarnegar, M. Rancier, S. Alrasheedi, C. Caillard, A. Ayav, G. Weryha, E. Mirallie, L. Bresler, Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. Surgery. 146(6), 1035–1041 (2009)PubMedCrossRef L. Brunaud, A. Germain, R. Zarnegar, M. Rancier, S. Alrasheedi, C. Caillard, A. Ayav, G. Weryha, E. Mirallie, L. Bresler, Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. Surgery. 146(6), 1035–1041 (2009)PubMedCrossRef
36.
go back to reference A. Tomaschitz, E. Ritz, B. Pieske, A. Fahrleitner-Pammer, K. Kienreich, J.H. Horina, C. Drechsler, W. März, M. Ofner, T.R. Pieber, S. Pilz, Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc. Res. 94(1), 10–19 (2012)PubMedCrossRef A. Tomaschitz, E. Ritz, B. Pieske, A. Fahrleitner-Pammer, K. Kienreich, J.H. Horina, C. Drechsler, W. März, M. Ofner, T.R. Pieber, S. Pilz, Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc. Res. 94(1), 10–19 (2012)PubMedCrossRef
37.
go back to reference A.A. Zia, G. Kamalov, K.P. Newman, J.E. McGee, S.K. Bhattacharya, R.A. Ahokas, Y. Sun, I.C. Gerling, K.T. Weber, From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation. Hypertens. Res. 33(11), 1091–1101 (2010)PubMedCrossRef A.A. Zia, G. Kamalov, K.P. Newman, J.E. McGee, S.K. Bhattacharya, R.A. Ahokas, Y. Sun, I.C. Gerling, K.T. Weber, From aldosteronism to oxidative stress: the role of excessive intracellular calcium accumulation. Hypertens. Res. 33(11), 1091–1101 (2010)PubMedCrossRef
38.
go back to reference G. Kamalov, W. Zhao, A.U. Shahbaz, S.K. Bhattacharya, Y. Sun, I.C. Gerling, K.T. Weber, Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism. Am. J. Physiol. Heart. Circ. Physiol. 298(2), H385–H394 (2010)PubMedCrossRefPubMedCentral G. Kamalov, W. Zhao, A.U. Shahbaz, S.K. Bhattacharya, Y. Sun, I.C. Gerling, K.T. Weber, Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism. Am. J. Physiol. Heart. Circ. Physiol. 298(2), H385–H394 (2010)PubMedCrossRefPubMedCentral
39.
go back to reference C. Bosworth, M.C. Sachs, D. Duprez, A.N. Hoofnagle, J.H. Ix, D.R. Jacobs Jr, D.S. Siscovick, B. Kestenbaum, I.H. de Boer, Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis. Clin. Endocrinol (Oxf). 79(3), 429–436 (2013)PubMedCrossRefPubMedCentral C. Bosworth, M.C. Sachs, D. Duprez, A.N. Hoofnagle, J.H. Ix, D.R. Jacobs Jr, D.S. Siscovick, B. Kestenbaum, I.H. de Boer, Parathyroid hormone and arterial dysfunction in the multi-ethnic study of atherosclerosis. Clin. Endocrinol (Oxf). 79(3), 429–436 (2013)PubMedCrossRefPubMedCentral
40.
go back to reference A. Ekmekci, N. Abaci, O.N. Colak, A. Agayev, N. Aksakal, H. Oflaz, N. Erginel-Unaltuna, Y. Erbil, Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism. J. Endocrinol. Invest. 32(7), 611–616 (2009)PubMedCrossRef A. Ekmekci, N. Abaci, O.N. Colak, A. Agayev, N. Aksakal, H. Oflaz, N. Erginel-Unaltuna, Y. Erbil, Endothelial function and endothelial nitric oxide synthase intron 4a/b polymorphism in primary hyperparathyroidism. J. Endocrinol. Invest. 32(7), 611–616 (2009)PubMedCrossRef
41.
go back to reference G. Schillaci, G. Pucci, M. Pirro, M. Monacelli, A.M. Scarponi, M.R. Manfredelli, F. Rondelli, N. Avenia, E. Mannarino, Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis. 218(1), 96–101 (2011)PubMedCrossRef G. Schillaci, G. Pucci, M. Pirro, M. Monacelli, A.M. Scarponi, M.R. Manfredelli, F. Rondelli, N. Avenia, E. Mannarino, Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism. Atherosclerosis. 218(1), 96–101 (2011)PubMedCrossRef
42.
go back to reference V. Nuzzo, L. Tauchmanovà, F. Fonderico, R. Trotta, M.R. Fittipaldi, D. Fontana, Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur. J. Endocrinol. 147(4), 453–459 (2002)PubMedCrossRef V. Nuzzo, L. Tauchmanovà, F. Fonderico, R. Trotta, M.R. Fittipaldi, D. Fontana, Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur. J. Endocrinol. 147(4), 453–459 (2002)PubMedCrossRef
43.
go back to reference S.A. Camacho, R. Brandes, V.M. Figueredo, M.V. Weiner, Ca2 + transient decline and myocardial relaxation are slowed during low flow ischemia in rat hearts. J. Clin. Invest. 93(3), 951–957 (1994)PubMedCrossRefPubMedCentral S.A. Camacho, R. Brandes, V.M. Figueredo, M.V. Weiner, Ca2 + transient decline and myocardial relaxation are slowed during low flow ischemia in rat hearts. J. Clin. Invest. 93(3), 951–957 (1994)PubMedCrossRefPubMedCentral
44.
go back to reference J.A. Lax, A.M. Bermann, T.F. Cianciulli, L.A. Morita, O. Masoli, H.A. Prezioso, Estimation of the ejection fraction in patients with myocardial infarction obtained from the combined index of systolic and diastolic left ventricular function: a new method. J. Am. Soc. Echocardiogr. 13(2), 116–123 (2000)PubMedCrossRef J.A. Lax, A.M. Bermann, T.F. Cianciulli, L.A. Morita, O. Masoli, H.A. Prezioso, Estimation of the ejection fraction in patients with myocardial infarction obtained from the combined index of systolic and diastolic left ventricular function: a new method. J. Am. Soc. Echocardiogr. 13(2), 116–123 (2000)PubMedCrossRef
45.
go back to reference C. Tei, New non-invasive index for combined systolic and diastolic ventricular function. J. Cardiol. 26(2), 135–136 (1995)PubMed C. Tei, New non-invasive index for combined systolic and diastolic ventricular function. J. Cardiol. 26(2), 135–136 (1995)PubMed
46.
go back to reference L. Ascione, M. De Michele, M. Accadia, S. Rumolo, L. Damiano, A. D’Andrea, P. Guarini, B. Tuccillo, Myocardial global performance index as a predictor of in hospital cardiac events in patients with first myocardial infarction. J. Am. Soc. Echocardiogr. 16(10), 1019–1023 (2003)PubMedCrossRef L. Ascione, M. De Michele, M. Accadia, S. Rumolo, L. Damiano, A. D’Andrea, P. Guarini, B. Tuccillo, Myocardial global performance index as a predictor of in hospital cardiac events in patients with first myocardial infarction. J. Am. Soc. Echocardiogr. 16(10), 1019–1023 (2003)PubMedCrossRef
47.
go back to reference T.H. Marwick, Measurement of strain and strain rate by echocardiography: ready for prime time? J. Am. Coll. Cardiol. 47(7), 1313–1327 (2006)PubMedCrossRef T.H. Marwick, Measurement of strain and strain rate by echocardiography: ready for prime time? J. Am. Coll. Cardiol. 47(7), 1313–1327 (2006)PubMedCrossRef
48.
go back to reference T. Edvardsen, H. Skulstad, S. Aakhus, S. Urheim, H. Ihlen, Regional myocardial systolic function during acute myocardial ischemia assessed by strain Doppler echocardiography. J. Am. Coll. Cardiol. 37(3), 726–730 (2001)PubMedCrossRef T. Edvardsen, H. Skulstad, S. Aakhus, S. Urheim, H. Ihlen, Regional myocardial systolic function during acute myocardial ischemia assessed by strain Doppler echocardiography. J. Am. Coll. Cardiol. 37(3), 726–730 (2001)PubMedCrossRef
49.
go back to reference M.S. Alpaydın, E. Aksakal, M.K. Erol, Z. Simşek, M. Açıkel, S. Arslan, F. Gündoğdu, S. Sevimli, S. Karakelleoğlu, Assessment of regional left ventricular functions by strain and strain rate echocardiography in type II diabetes mellitus patients without microvascular complications. Turk Kardiyol. Dern. Ars. 39(5), 378–384 (2011)PubMedCrossRef M.S. Alpaydın, E. Aksakal, M.K. Erol, Z. Simşek, M. Açıkel, S. Arslan, F. Gündoğdu, S. Sevimli, S. Karakelleoğlu, Assessment of regional left ventricular functions by strain and strain rate echocardiography in type II diabetes mellitus patients without microvascular complications. Turk Kardiyol. Dern. Ars. 39(5), 378–384 (2011)PubMedCrossRef
50.
go back to reference L. Ernande, E.R. Rietzschel, C. Bergerot, M.L. De Buyzere, F. Schnell, L. Groisne, M. Ovize, P. Croisille, P. Moulin, T.C. Gillebert, G. Derumeaux, Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. J. Am. Soc. Echocardiogr. 23(12), 1266–1272 (2010)PubMedCrossRef L. Ernande, E.R. Rietzschel, C. Bergerot, M.L. De Buyzere, F. Schnell, L. Groisne, M. Ovize, P. Croisille, P. Moulin, T.C. Gillebert, G. Derumeaux, Impaired myocardial radial function in asymptomatic patients with type 2 diabetes mellitus: a speckle-tracking imaging study. J. Am. Soc. Echocardiogr. 23(12), 1266–1272 (2010)PubMedCrossRef
51.
go back to reference Y.C. Ku, M.E. Liu, C.S. Ku, T.Y. Liu, S.L. Lin, Relationship between vitamin D deficiency and cardiovascular disease. World J. Cardiol. 5(9), 337–346 (2013)PubMedCrossRefPubMedCentral Y.C. Ku, M.E. Liu, C.S. Ku, T.Y. Liu, S.L. Lin, Relationship between vitamin D deficiency and cardiovascular disease. World J. Cardiol. 5(9), 337–346 (2013)PubMedCrossRefPubMedCentral
52.
go back to reference L. Wang, Y. Song, J.E. Manson, S. Pilz, W. März, K. Michaëlsson, A. Lundqvist, S.K. Jassal, Barrett-Connor, C. Zhang, C.B. Eaton, H.T. May, J.L. Anderson, H.D. Sesso, Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes. 5(6), 819–829 (2012)PubMedCrossRefPubMedCentral L. Wang, Y. Song, J.E. Manson, S. Pilz, W. März, K. Michaëlsson, A. Lundqvist, S.K. Jassal, Barrett-Connor, C. Zhang, C.B. Eaton, H.T. May, J.L. Anderson, H.D. Sesso, Circulating 25-hydroxy-vitamin D and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes. 5(6), 819–829 (2012)PubMedCrossRefPubMedCentral
53.
go back to reference M.D. Walker, E. Cong, A. Kepley, M.R. Di Tullio, T. Rundek, S. Homma, J.A. Lee, R. Liu, P. Young, C. Zhang, D.J. McMahon, S.J. Silverberg, Association between Serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 99(2), 671–680 (2014)PubMedCrossRef M.D. Walker, E. Cong, A. Kepley, M.R. Di Tullio, T. Rundek, S. Homma, J.A. Lee, R. Liu, P. Young, C. Zhang, D.J. McMahon, S.J. Silverberg, Association between Serum 25-hydroxyvitamin D level and subclinical cardiovascular disease in primary hyperparathyroidism. J. Clin. Endocrinol. Metab. 99(2), 671–680 (2014)PubMedCrossRef
Metadata
Title
Evaluation of left ventricle functions by tissue Doppler, strain, and strain rate echocardiography in patients with primary hyperparathyroidism
Authors
Didem Ozdemir
Gulhan Yuksel Kalkan
Nihal Akar Bayram
Eda Demir Onal
Reyhan Ersoy
Engin Bozkurt
Bekir Cakir
Publication date
01-11-2014
Publisher
Springer US
Published in
Endocrine / Issue 2/2014
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-014-0245-7

Other articles of this Issue 2/2014

Endocrine 2/2014 Go to the issue